About
Faron Pharmaceuticals is a clinical-stage biopharmaceutical company developing immunotherapies targeting myeloid cells, including their lead candidate bexmarilimab, for the treatment of hematological cancers and solid tumors.
Explore Faron Pharmaceuticals Ltd's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.